Kidney Cancer Association presents rising star award healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Myriad to support MD Anderson researchers studying metastatic renal cell carcinoma treatment selection and responseSALT LAKE CITY, June 12, 2023 Myriad Genetics, Inc., a leader in genetic. | June 12, 2023
In patients with advanced clear cell renal cell carcinoma, an optimal sitravatinib dose combined with a fixed dose of nivolumab improved outcomes in a phase 1-2 trial.
SUO 2021 Adjuvant therapy for high-risk non-metastatic RCC, there is unmet statistical, interventional, and observational research needed to be addressed to further improve the adjuvant treatment landscape for patients in this disease space.